Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 4”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Early research (Phase 1)Study completedNCT01806909
What this trial is testing

Intranasal AD4-H5-VTN as an Adenovirus Vaccine

Who this might be right for
Healthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 51
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Testing effectiveness (Phase 2)Ended earlyNCT00602680
What this trial is testing

Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sanofi 1
Large-scale testing (Phase 3)Ended earlyNCT05310071
What this trial is testing

Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 1,027
Testing effectiveness (Phase 2)Study completedNCT03461861
What this trial is testing

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development

Who this might be right for
APOE 4
Medical College of Wisconsin 26
Large-scale testing (Phase 3)Study completedNCT05108922
What this trial is testing

Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Who this might be right for
Mild Cognitive Impairment (MCI)Alzheimer Disease
Eli Lilly and Company 148
Large-scale testing (Phase 3)Looking for participantsNCT06702124
What this trial is testing

Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 348
Early research (Phase 1)Looking for participantsNCT06372821
What this trial is testing

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Who this might be right for
Alzheimer DiseaseAutosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)+1 more
University College, London 10
Large-scale testing (Phase 3)Ended earlyNCT00998764
What this trial is testing

A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 494
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60
Not applicableStudy completedNCT05309577
What this trial is testing

Self-Care for Dementia Caregivers

Who this might be right for
AgingMental DisorderEating, Healthy+6 more
University of Pittsburgh 21
Not applicableUnknownNCT02835716
What this trial is testing

Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO

Who this might be right for
Alzheimer Disease
Millennium Magnetic Technologies, LLC 150
Early research (Phase 1)Study completedNCT01006798
What this trial is testing

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Who this might be right for
Bird FluInfluenza
Emergent BioSolutions 166
Testing effectiveness (Phase 2)Study completedNCT00040443
What this trial is testing

Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.

Who this might be right for
Mild Cognitive Impairment
RespireRx 175
Post-approval studies (Phase 4)Looking for participantsNCT07633470
What this trial is testing

Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Who this might be right for
Alzheimer Disease
Alpha Cognition, Inc 150
Early research (Phase 1)Study completedNCT01979406
What this trial is testing

Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines

Who this might be right for
Anthrax Infection
Emergent BioSolutions 120
Early research (Phase 1)Ended earlyNCT01137799
What this trial is testing

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Who this might be right for
SchizophreniaAlzheimer's DiseaseCognition Disorders
Janssen Pharmaceutica N.V., Belgium 47
Early research (Phase 1)Study completedNCT05532358
What this trial is testing

A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)

Who this might be right for
Healthy Volunteers
MODAG GmbH 54
Early research (Phase 1)Study completedNCT01989533
What this trial is testing

Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers

Who this might be right for
Vaccine Response
National Institute of Allergy and Infectious Diseases (NIAID) 62
Early research (Phase 1)Study completedNCT04685265
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease

Who this might be right for
Parkinson Disease
MODAG GmbH 70
Next Page